Drug Shortage Report for PRIVA-IRBESARTAN
Report ID | 83539 |
Drug Identification Number | 02446502 |
Brand name | PRIVA-IRBESARTAN |
Common or Proper name | IRBESARTAN 150 MG |
Company Name | PHARMAPAR INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | IRBESARTAN |
Strength(s) | 150MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | C09CA |
ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-05-08 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2019-05-09 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1565 BOUL LIONEL-BOULET VARENNES, QUEBEC CANADA J3X 1P7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2019-05-09 | English | Compare |
v2 | 2019-05-08 | French | Compare |
v1 | 2019-05-08 | English | Compare |
Showing 1 to 3 of 3